SEC Form 4 · accession 0001493152-16-009658
TearLab Corp · TEAR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Jensen
Officer — President and CEO
Period of report
May 9, 2016
Accepted (ET)
May 11, 2016 · 6:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001299139
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 9, 2016 | P$0 | 133,332 | — | A | 225,400 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF1,F2 | $1.125 | May 9, 2016 | P | 66,666 | A | — | May 9, 2021 | Common Stock | 66,666 | 66,666 | D |
Explanation of responses
- F1The reported securities are included within 133,332 Class A Units of TEAR, purchased by the reporting person for $0.75 per Unit. Each Unit consists of one share of common stock and a warrant to purchase 0.5 shares of common stock at an exercise price of $1.125 per full share of common stock.
- F2The warrant will be exercisable from the later of (i) stockholder approval to increase the authorized number of shares of common stock of TEAR, and (ii) 12 months from the date of issuance and will expire five years from the date on which such warrant becomes exercisable.